Relay Therapeutics Inc
Follow $RLAY
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $RLAY by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is RLAY moving today?
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
RLAY overview
Related filings and maps
Congress activity in RLAY
No receipt-qualified Congressional disclosure is present for RLAY in the cached public ledger.
RLAY contract awards, year to date.
Public federal awards linked to this ticker.
RLAY lobbying filings, year to date.
Registered lobbying filings matched to Relay Therapeutics Inc.